Health Determinants Of A Patient With A Diagnosis Of Copd And Anemia

I will analyse the prevalence of the condition and what the potential causes may be. My interests have been directed to pre hospital care and community lead treatment packages, which are potentially available to the patient, as this is the acute environment, which I will have contact with in my employment as a paramedic. The initial reading was to understand COPD as a chronic condition, what is COPD? and its prevalence in the population. The (World health organisation, 2000), states that one in four deaths in the world are caused by COPD. In 2010 (Vos T Flaxman etal, 2012), says globally there were approximately 329 million, which is 4.8% of the population who are affected by this chronic condition, In the UK (NICE, 2010), have estimated that 3 million people suffer from COPD, with more yet to be diagnosed. This information about the amount of people living with this condition was surprising, as I little knowledge of its existence. During the early 1960’s (Timothy Q. Howes, 2005), says the term COPD had been designated as a single term unifying all the chronic respiratory diseases. Since then the term COPD, has been sub divided in to three umbrella areas, Bronchitis, Emphysema and Chronic asthma, which are separate conditions, which I have been previously aware of as their individual conditions. The 58 year old patient who we visited,

This is a case study on a 76 year old man.Mr Alan Chari(pseudonym used to protect the identity of a patient),was admitted over night in my department.He is a divorcee who stays with son.He is a retired teacher and his son is permanently employed by a local company as an electrician.He is independent with activities of daily livings but is occasionally limited by his ill health.He used to be a heavy smoker .After realising the burden COPD has on general New Zealand population ,affecting about15% of the adult population over the age of 45 years according to asthmanz( 2010) ,l took this case study to gain in-depth understanding.

R.W. appears with progressive difficulty getting his breath while doing simple tasks, and also having difficulty doing any manual work, complains of a cough, fatigue, and weight loss, and has been treated for three respiratory infections a year for the past 3 years. On physical examination, CNP notice clubbing of his fingers, use accessory muscles for respiration, wheezing in the lungs, and hyperresonance on percussion of the lungs, and also pulmonary function studies show an FEV1 of 58%. These all symptoms and history represented here most strongly indicate the probability of chronic obstructive pulmonary disease (COPD). COPD is a respiratory disease categorized by chronic airway inflammation, a decrease in lung function over time, and gradual damage in quality of life (Booker, 2014).

51 patients (46.8%) were assigned to the case cohort and 58 patients (53.2%) were assigned to the control cohort. The difference in the rate of 30-day readmission between cases (21.6%) and controls (13.8%) was not statistically significant (P = 0.3203). The overall rate of 30-day readmission in the study population was 17.4%. The mean hospital length of stay was similar between both groups. A history of COPD exacerbation in the preceding 12 months was the only significant predictor of 30-day readmission (P = 0.0114). The mean PIF (50.4 ± 19.35 L/min, n = 49) was similar between the patients with a 30-day readmission and those without (P = 0.7608). There was a significant negative correlation between PIF and patient’s age (r = -0.378; P =

A review of the medical records indicates that she was admitted to MMHS from 1/22 to 2/7/17 for shortness of breath and cough. She was diagnosed and treated for pneumonia with antibiotic therapy. She suffers from multiple medical illnesses includes chronic CHF with shortness of breath. She uses oxygen 2-3 L/Min, chronic stable HTN, Chronic poorly controlled DM and chronic anxiety.

6MWT is commonly used to assess the COPD patient’s functional status. 6MWT is widely used for cardiopulmonary patients in hospital settings since it is safer, easier and cost efficient to administer than other walk tests. It better reflects activities of daily life than other walk tests and it adequately anticipates morbidity and mortality of COPD patients (Pinto-Plata et al. 2004; Enright 2003). According to Andersson et al.(2011), 6MWT has a strong reliability with an Intraclss Correlation Coefficient of 0.94. Furthermore, the validity of the 6MWT is established by the relationship between 6MWT and peak oxygen consumption(VO2peak) which is moderate to good based on exercise test done in patients with COPD (Jenkins 2007). This test is clinically

Sitting at triage, this particular night was busy but not chaotic when a father and son approached to be assessed; pt had been unwell with his asthma for the day and had been following his asthma plan but was not responding to the treatment dad stated pt has unstable asthma and has one presentation to intensive care unit pt was alert orientated talking in full sentences but had wide spread wheeze bilaterally saturations 98% room air mild work of breathing noted. Started treatment in triage room ventolin (five milligrams bronchodilator that relaxes smooth muscles) and atrovent (five micrograms bronchodilator for bronchospasm) nebulizer given with good effect patient was given a category 3 to be seen in half an hour.

Dr. Holland started off his presentation talking about one of his patients. This woman was healthy previous to her going to the ER. She had acute dyspnea and couldn’t breathe. The patients had progressive hypoxia, fever, leukocytosis. They started to treat her

For this study, subjects with and without COPD will be recruited through advertising numerous flyers around hospitals and clinics in the Suwanee area. A total of eighty patients will be used, half with and half without chronic COPD. Patients will be asked to come to the PCOM Georgia campus to fill out a health questionnaire form. From the given information, patients will be put into either treatment or placebo groups at random who are given epinephrine and placebo treatments over a period of ten sessions. The randomization will be equally divided among patients with and without the disease to provide adequate statistical analysis. Each session will last one hour to use a spirometer to measure inspiratory, expiratory, and total lung

The patient is a 73-year old white female who symptoms started 2 days prior to presentation. She started with a headache, progressive throat pain, having fever, cough and severe runny nose. Different doctor in Dr. Makar’s office saw her and placed on Zithromax however symptoms worsened and she presented to the hospital. Her medical history is significant for hypertension, COPD, dyslipidemia, depression, anxiety, GERD she also has a history of falls with injuries to the rotator cuff, Rib fractures and pneumothorax. She is an ex smoker she smoked a pack and a half a day. She worked as a nurse at the Englewood Hospital. She quit 10 years ago and she is widowed her husband having died from lung cancer. On presentation to the ED her BP is

The patient has had several emergency room visits, at which time it seemed like the nebulizer treatments did a better job of, “Stopping her symptoms.”

The patient is 60-year-old female who presents the ED with altered mental status. She has been screaming and yelling which is not her baseline. She is normally alert, awake and oriented. Her medical history is significant for end-stage renal disease, multiple myeloma, and hypertension. The patient was in the Lincoln Park for rehabilitation. She was discharged on April 28, 2017, with generalized weakness. She has been treated for multiple myeloma last chemo being April 24, 2017. She also had phlebitis in the past, hypertension, dyslipidemia, hiatal hernia, and ulcerative colitis. The work up done in the ED initially the CAT scan was interperted as showing no significant change from an MRI done subsequent to the patient's change in behavior

History of Present Illness: Mr. Goldstein is here for followup of his pulmonary function tests, CT scan, and sleep study. He states that his dyspnea is improved after initiation of Advair HFA. He still is complaining of some fatigue, shortness of breath and general malaise. The thyroid function testing was grossly abnormal and he is being evaluated by Core Physician Endocrinology in the next one to two months. Otherwise, he states his cough is markedly improved. He is still using tobacco products, roughly one pack daily and he does have a CPAP machine at home, however has not initiated any therapy for his OSA.

On admission, a complete physical assessment was performed along with a blood and metabolic panel. The assessment revealed many positive and negative findings. J.P. was positive for dyspnea and a productive cough. She also

Recently I took care of a patient N.S, 77-year-old male diagnosed with pneumonia by an ER doctor. He transferred to hospital acute care medical unit after a few hours of stay in the ER. SBAR from ER gave information on N.S: No known allergies, full code, NIBP 158/83, Heart Rate (HR) 92 beats per minute, Temperature 36.8, respiration rate 18 breaths per minute, regular with decreased breath sounds to the bilateral bases lower lungs, SPO2 98% 0n 2LNP. N.S has an occasional productive cough and shortness of breath on exertion (SOBOE). N.S has a history of MI x 1 (dates not mentioned) and coronary artery bypass graft (2009), HTN, and hyperlipidemia, asthma (for unknown years).